Skip to content

Catechin Gargling for Influenza Infection

A Randomized Clinical Study of Catechin Gargling Effects on the Prevention of Influenza Infection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00239213
Enrollment
400
Registered
2005-10-14
Start date
2005-11-30
Completion date
2006-04-30
Last updated
2006-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza Infection

Keywords

catechins, gargling, healthy volunteers

Brief summary

The purpose of this study is to clarify the preventive effects of catechin gargling on the influenza infection.

Detailed description

In-vitro experimental studies have revealed that tea catechin extracts induce preventive effects on influenza infection. However, few studies have been conducted on the effects of tea gargling on influenza infection, and the clinical evidence is unclear. Also there have been no studies reported on the gargling effects with tea catechin extracts on the prevention of influenza infection.

Interventions

Sponsors

Shizuoka General Hospital
CollaboratorUNKNOWN
Seirei Hamamatsu General Hospital
CollaboratorOTHER
White Cross Nursing Home
CollaboratorOTHER
University of Shizuoka
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy volunteers * aged 20 to 65 years old * obtained written informed concent before participation * inoculated with influenza vaccine before entering the study

Exclusion criteria

* other gargling except water during the study * possessing tea allergy

Design outcomes

Primary

MeasureTime frame
Incidence rates of influenza infection during the study

Secondary

MeasureTime frame
severity of symptoms including complications and hospitalization

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026